ELARIS AG
ELS | MU
Overview
Corporate Details
- ISIN(s):
- DE000A2QDEZ3 (+1 more)
- LEI:
- 894500ZKLHK0AXWXHQ43
- Country:
- Germany
- Address:
- Industriestraße 19, 67269 Grünstadt
- Website:
- https://www.elaris.eu/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
At ELARIS we’ve made it our goal to provide electric mobility for real life. We achieve this through available, innovative and affordable e-vehicles, charging infrastructure, products, and services from a single source that are geared towards people's everyday needs. Everything is of the best quality, at a fair price, and for people who place the highest value on mobility that meets their daily requirements. ELARIS focuses its offer on the greatest utility value for its customers. In order to know and serve this benefit, ELARIS is the e-mobility provider with the best contact and closest proximity to its customers. In fact, our customers’ feedback will be incorporated into future vehicle designs. This is how we make ELARIS useful, affordable and above all: human. ELARIS is the human among e-cars. That is Human E.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-01-21 16:25 |
Legal Proceedings Report
Die ELARIS AG stellt einen Antrag auf Eroffnung eines Insolvenzverfahrens
|
German | 5.7 KB | |
| 2025-01-20 16:25 |
Legal Proceedings Report
Die ELARIS AG stellt einen Antrag auf Eroffnung eines Insolvenzverfahrens
|
German | 5.7 KB | |
| 2025-01-07 14:00 |
Earnings Release
ELARIS AG muss Umsatzprognose fur 2024 aufgrund von EU-Strafzollen anpassen
|
German | 6.0 KB | |
| 2025-01-06 14:00 |
Earnings Release
ELARIS AG muss Umsatzprognose fur 2024 aufgrund von EU-Strafzollen anpassen
|
German | 6.0 KB | |
| 2024-11-11 16:00 |
Board/Management Information
ELARIS AG: Aufsichtsratsvorsitzender der ELARIS AG legt sein Amt zum 9. Dezembe…
|
German | 7.1 KB | |
| 2024-11-07 11:48 |
Board/Management Information
ELARIS AG strengthens internal structures to enable further growth / Steffen Co…
|
English | 6.6 KB | |
| 2024-10-10 09:30 |
Regulatory News Service
ELARIS AG is considering the possibility of offshoring SKD production in respon…
|
English | 6.1 KB | |
| 2024-09-17 09:14 |
Earnings Release
ELARIS AG posts its first positive operating result in the first half of 2024 a…
|
English | 8.0 KB | |
| 2024-08-28 18:00 |
Director's Dealing
ELARIS AG: Elaris Holding GmbH, Aktienverkauf. [Die verkauften Aktien der ELARI…
|
German | 8.1 KB | |
| 2024-08-26 20:02 |
Director's Dealing
ELARIS AG: Elaris Holding GmbH, Tausch (Abgang) von Stuck 2.670 Aktien der ELAR…
|
German | 7.9 KB | |
| 2024-08-26 20:01 |
Director's Dealing
ELARIS AG: Elaris Holding GmbH, Aktienverkauf. [Die verkauften Aktien der ELARI…
|
German | 8.1 KB | |
| 2024-08-26 20:00 |
Director's Dealing
ELARIS AG: Elaris Holding GmbH, Aktienverkauf. [Die verkauften Aktien der ELARI…
|
German | 8.1 KB | |
| 2024-08-23 18:20 |
Post-Annual General Meeting Information
ELARIS AG: Annual General Meeting approves all agenda items with a clear majori…
|
English | 5.0 KB | |
| 2024-08-14 20:15 |
Share Issue/Capital Change
ELARIS AG implements planned adjustment of borrowing structure and increases fr…
|
English | 5.3 KB | |
| 2024-08-14 20:07 |
Director's Dealing
ELARIS AG: Elaris Holding GmbH, Aktienverkauf. [Die verkauften Aktien der ELARI…
|
German | 8.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |